Review decision date: February 2014

Review decision: 

Following consultation with stakeholders this guideline has now been placed on the static list.

The guideline should cross refer to technology appraisal guidance 265,  Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours.

Next review date: TBC

The advice in the NICE guideline covers:

  • adults who have, or are at risk of developing, metastatic spinal cord compression because they have cancer elsewhere in their body that has spread to their spine

It does not specifically look at:

  • children, or adults whose cancer started in the spine or who have compression of the spinal cord that is not caused by cancer
  • National Institute for Health and Care Excellence (NICE) accreditation logo